Sleep Apnea – FDA Approval

Angie Szumlinski Featured, Studies

The U.S. Food and Drug Administration authorized marketing a new prescription-only device intended to reduce snoring and mild obstructive sleep apnea. Unlike devices used while patients sleep, this is the first device used while awake that is intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backward and obstructing the airway during sleep. …